SHW
61
2
SO
70
-3
EW
40
2
AEP
56
-2
MU
43
-4
SWN
30
-12
FLS
50
-3
COF
60
-4
VMC
57
3
PEG
41
-3
LLY
73
-3
PDCO
57
2
DNB
36
2
T
45
3
KLAC
65
-2
FIS
50
-3
K
30
-2
HAL
41
11
GWW
46
2
CMA
39
3
SHW
61
2
SO
70
-3
EW
40
2
AEP
56
-2
MU
43
-4
SWN
30
-12
FLS
50
-3
COF
60
-4
VMC
57
3
PEG
41
-3
LLY
73
-3
PDCO
57
2
DNB
36
2
T
45
3
KLAC
65
-2
FIS
50
-3
K
30
-2
HAL
41
11
GWW
46
2
CMA
39
3
Financhill
Back

Koninklijke DSM NV Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
40

KDSKF
Koninklijke DSM NV

Last Price:
45.00
Seasonality Move:
-2.96%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
40
Koninklijke DSM NV (KDSKF) is a Sell

Is Koninklijke DSM NV a Buy, Sell or Hold?

  • The current Koninklijke DSM NV [KDSKF] share price is $45.00. The Score for KDSKF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • KDSKF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KDSKF Stock Price Chart

What is Koninklijke DSM NV's stock price today?

  • The Koninklijke DSM NV share price today is $45.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KDSKF is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

KDSKF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 68.02 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.93 - 40.27) Buy
Bollinger Bands (100): (28.73 - 75.65) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

KDSKF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40 Buy
20-day SMA: 37 Buy
50-day SMA: 52.04 Sell
200-day SMA: 45.24 Sell
8-day EMA: 41.34 Buy
20-day EMA: 39.43 Buy
50-day EMA: 44.05 Buy
200-day EMA: 55.58 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Koninklijke DSM NV Earnings Growth & KDSKF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Koninklijke DSM NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):